368 related articles for article (PubMed ID: 18516027)
21. [Multimodal therapy of esophageal cancer].
Hartwig W; Strobel O; Lordick F; Büchler MW; Werner J
Z Gastroenterol; 2008 Oct; 46(10):1207-13. PubMed ID: 18937192
[TBL] [Abstract][Full Text] [Related]
22. [The role of radiotherapy in the management of esophageal cancer].
Serkies K; Badzio A; Jassem J
Pol Merkur Lekarski; 2005 Mar; 18(105):332-5. PubMed ID: 15997646
[TBL] [Abstract][Full Text] [Related]
23. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
24. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
25. [Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma].
Yang H; Fu JH; Hu Y; Lin P; Liu MZ; Li Q; Fang ZC; Hu YH
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(45):3182-5. PubMed ID: 19171088
[TBL] [Abstract][Full Text] [Related]
26. Multimodality therapy of local regional esophageal cancer.
Kelsen DP
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
[TBL] [Abstract][Full Text] [Related]
27. New developments in the treatment of esophageal cancer.
Ilson DH
Clin Adv Hematol Oncol; 2004 Feb; 2(2):97-104. PubMed ID: 16163169
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant therapy of esophageal carcinoma.
Reed CE
Chest Surg Clin N Am; 1994 May; 4(2):299-314. PubMed ID: 8049998
[TBL] [Abstract][Full Text] [Related]
29. Multimodality Therapy for Esophageal Cancer.
Siewert JR; Stein HJ; Fink U
Oncologist; 1996; 1(4):210-218. PubMed ID: 10387990
[TBL] [Abstract][Full Text] [Related]
30. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Siewert JR; Lordick F; Ott K; Stein HJ; Weber WA; Becker K; Peschel C; Fink U; Schwaiger M
Ann Surg; 2007 Oct; 246(4):624-8; discussion 628-31. PubMed ID: 17893499
[TBL] [Abstract][Full Text] [Related]
31. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant therapy for esophageal cancer: surgical considerations.
Piraino A; Vita ML; Tessitore A; Cusumano G; Congedo MT; Margaritora S; Porziella V; Meacci E; Cesario A; Granone P
Rays; 2006; 31(1):37-45. PubMed ID: 16999374
[TBL] [Abstract][Full Text] [Related]
33. Targeted therapies for esophageal cancer.
Tew WP; Kelsen DP; Ilson DH
Oncologist; 2005 Sep; 10(8):590-601. PubMed ID: 16177283
[TBL] [Abstract][Full Text] [Related]
34. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response.
Geh JI; Bond SJ; Bentzen SM; Glynne-Jones R
Radiother Oncol; 2006 Mar; 78(3):236-44. PubMed ID: 16545878
[TBL] [Abstract][Full Text] [Related]
35. [Combined radiochemotherapy in treatment of esophageal cancers].
Bosset JF; Gignoux M; Mantion G; Heyd B; Salame E; Queneau PE; Lorchel F
Ann Chir; 1998; 52(2):185-91. PubMed ID: 9752439
[TBL] [Abstract][Full Text] [Related]
36. [Do locally advanced esophageal cancer still need surgery?].
Hennequin C; Quero L; Baruch-Hennequin V; Maylin C
Cancer Radiother; 2008 Dec; 12(8):831-6. PubMed ID: 19046920
[TBL] [Abstract][Full Text] [Related]
37. [Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].
Jiang YY; Wu SX; Zhang P; Xie CY; Wang J; Sun CC
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2171-4. PubMed ID: 19080664
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
39. Emerging drugs for esophageal cancer.
Homs MY; Voest EE; Siersema PD
Expert Opin Emerg Drugs; 2009 Jun; 14(2):329-39. PubMed ID: 19453287
[TBL] [Abstract][Full Text] [Related]
40. Recent changes and the future roles of esophageal cancer surgery.
Nishimaki T; Shimoji H; Sunagawa H
Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):324-32. PubMed ID: 15658903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
